Table I.
Characteristics of the hyperlipidemic and control patients.
| Control (n=32) | Hyperlipidemia (n=72) | |
|---|---|---|
| Age (years) | 48.2±9.5 | 49.4±10.3 |
| Male (%) | 46.8 | 51.4 |
| Smokers (%) | 31.3 | 34.7 |
| Drinking (%) | 21.9 | 20.8 |
| Diabetes (%) | 28.1 | 25.0 |
| Hypertension (%) | 34.4 | 36.1 |
| Aspirin (%) | 15.6 | 19.4 |
| β-blocker (%) | 6.3 | 6.9 |
| Calcium blocker (%) | 25.0 | 27.8 |
| ACEI/ARB (%) | 18.8 | 19.4 |
| BMI (kg/m2) | 23.9±3.3 | 25.0±4.1 |
| TC (mmol/l) | 4.34±0.89 | 6.37±0.94a |
| TG (mmol/l) | 1.54±0.68 | 1.91±0.77 |
| HDL (mmol/l) | 1.06±0.31 | 0.98±0.35 |
| LDL (mmol/l) | 2.57±0.82 | 4.99±0.75a |
| hs-CRP (mg/l) | 1.53±0.45 | 3.91±1.06a |
| HMGB1 (ng/ml) | 2.11±0.95 | 5.42±1.56a |
Data are presented as means ± SD. Smoking, ≥half pack/d within three months before this study; Drinking, ≥50g/d white wine within three months before this study; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; HMGB1, high mobility group box 1 protein.
a
P<0.05, compared to the controls.